SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending after being selected for inclusion in the S&P 500 index, a move investors expect to generate significant demand from index-tracking funds. The announcement has sparked a mix of enthusiasm over potential price gains and debate regarding whether the move is a long-term catalyst or a short-term 'sell-the-news' event similar to other recent index additions.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are trending as investors weigh an expanded AI infrastructure partnership with Hewlett Packard Enterprise against broader market volatility ahead of the upcoming earnings report. While some traders express frustration with the recent price decline, others are maintaining a bullish outlook, viewing the stock as undervalued given its massive cloud infrastructure backlog.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently trading near 52-week lows, fueling intense debate between traders viewing the decline as a generational buying opportunity for a blue-chip dividend stock and bears who argue the company is struggling with poor brand perception, declining consumer traffic, and a lack of competitive menu value. While many participants express confidence in the firm's real estate value and long-term stability, others contend that the stock remains in a persistent downtrend as consumer discretionary spending softens.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is trending as investors rotate back into semiconductor equipment stocks following a broad sector recovery from recent selloffs. The community highlights the company's strong position in process-control technology and resilient demand for AI-driven chip infrastructure, despite ongoing concerns regarding valuation and exposure to U.S. export restrictions in China.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1983 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy shares are being driven by increased volatility and community attention surrounding the escalating geopolitical conflict in the Middle East, particularly reports of damage to natural gas infrastructure in Qatar. Traders are actively debating whether these supply disruptions create a structural long-term tailwind for U.S. LNG exporters or if the volatility is primarily driven by speculative overreaction to energy sector news.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

DIA is trending primarily due to investor focus on the Federal Reserve's path for interest rates, with the conversation dominated by strong August jobs data and speculation about potential rate hikes. The community remains divided, with many traders debating the Fed's next moves while expressing uncertainty regarding the broader economic landscape and regional geopolitical tensions.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased volatility and attention following its listing on the Upbit exchange, which traders are linking to a sharp spike in trading volume. While some participants are optimistic about potential price appreciation and infrastructure developments, others are dismissing the move as a typical pump-and-dump scheme, citing historical price patterns.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgen shares are trending following the FDA approval of IMDELLTRA for the treatment of small cell lung cancer, marking a key milestone for its oncology portfolio. Traders are also actively discussing the company's cardiometabolic pipeline and its role as a potential M&A player in the obesity drug space.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is experiencing significant upward price momentum driven by strong buying volume and a community sentiment that favors its privacy-focused technology as a potential alternative to Bitcoin. Traders are also citing excitement over the potential for increased institutional exposure and the company's limited circulating supply as key catalysts for the recent price rally.

Bitdeer Technologies Group engages in the cryptocurrency mining industry. It generates income through its proprietary mining datacenters. The firm handles complex processes involved in computing such as equipment procurement, transport logistics, datacenter design and construction, equipment management, and daily operations. The company was founded by Wu Jihan in December 2021 and is headquartered in Singapore.

Bitdeer Technologies Group. - Ordinary Shares - Class A

Bitdeer Technologies Holding Co

Bitdeer is trending as investors focus on its pivot from Bitcoin mining to AI data center infrastructure, bolstered by a significant 16-year, $4.7 billion lease for its Norway facility. While enthusiasm is high regarding the company's vertically integrated business model and potential hyperscaler deals, some traders express frustration with recent price volatility and skepticism regarding the timing of contract signatures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aurobindo Pharma Gets USFDA Nod for OTC Dextromethorphan Polistirex ER Suspension

… 2026. With this approval, Aurobindo Pharma ’s cumulative ANDA approvals … in Hyderabad, Aurobindo Pharma is an integrated global pharmaceutical company engaged in … generic and specialty pharmaceuticals , as well as active pharmaceutical ingredients (APIs), …

Brief India: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums and more

In this briefing: Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins 1. Sharda Cropchem - Continuing Momentum Despite Geopolitical Tantrums Sharda Cropchem is an asset-light agrochemical supplier that sources products mainly from China and India, sells globally, and builds competitive advantage through extensive regulatory product registrations instead of manufacturing capabilities. They invest heavily in product registrations, creating large pipeline that converts into revenue over time, driving strong cash flows funding growth internally, and supporting dividends despite high accounting amortization charges. Sharda’s massive registration pipeline and presence in regulated markets drive growth despite sourcing and forex risks.

Brief India: Primer: Anthem Biosciences (1234D IN) - Apr 2026 and more

In this briefing: Primer: Anthem Biosciences (1234D IN) - Apr 2026 Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins Gold Loan: How a Collateral-First Product Became India's Largest Retail Loan 1. Primer: Anthem Biosciences (1234D IN) - Apr 2026 Anthem Biosciences is a fully integrated Contract Research, Development, and Manufacturing Organization (CRDMO) providing end-to-end services for small and large molecules to the global pharmaceutical and biotechnology sectors. The company has demonstrated a strong financial track record, with a 32% CAGR in operating revenue between FY23 and FY25, and boasts industry-leading EBITDA margins. Key growth drivers include its leadership in fermentation capacity in India, expertise in advanced therapeutic modalities like ADCs and RNAi, and a strategic focus on backward integration to reduce reliance on external suppliers.

Brief India: Amagi Media Labs: Taking Media Companies to the Cloud Universe and more

In this briefing: Amagi Media Labs: Taking Media Companies to the Cloud Universe Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins Gold Loan: How a Collateral-First Product Became India's Largest Retail Loan The Adani Group Clearance: Deconstructing the CCI Verdict and What It Means for the Conglomerate 1. Amagi Media Labs: Taking Media Companies to the Cloud Universe Amagi's unified cloud-based media infrastructure serves to digitise traditional media content and enable monetisation. Its two-way platform supports not just the content-owners but also distributors globally with varied content access By attracting both media companies and distributors, Amagi benefits from a content-driven flywheel effect, creating structural stickiness with 120+% NRR and 35–50% cost savings for broadcasters. Amagi has been a key enabler for broadcasting for live-events (FIFA, NFL) while its content library attracts small/new OTT platforms.

Brief Multi-Strategy: Approaches Aimed at Resolving “parent-Subsidiary Listings” in the Broad Sense Remain Effective and more

In this briefing: Approaches Aimed at Resolving “parent-Subsidiary Listings” in the Broad Sense Remain Effective Charting Course: Oil Cognitive Arbitrage and the PetroYuan Debut (4/17/26) HEW: Rallying into the Void Japan Strategy Weekly Paracetamol’s Supply Crisis: The Tablet Squeezing Indian Pharma Margins 1. Approaches Aimed at Resolving “parent-Subsidiary Listings” in the Broad Sense Remain Effective A common challenge faced by Japanese companies is inability to concentrate resources on businesses with high profit margins and growth potential, resulting in failure to successfully expand promising businesses overseas. Establishing and implementing clear criteria for deciding when to invest in or withdraw from businesses is essential for restructuring the business portfolio. The litmus test is eliminating parent-subsidiary dual listings. The Standard Market is likely to become the main battleground for efforts to resolve parent-subsidiary dual listings.In the Prime Market, increased approaches from activist investors targeting equity-method affiliates are inevitable. 2.

Breakout Brewing In Healthcare Stocks: SEBI Analyst Sees Potential In These Four Stocks

Equity

The analyst highlights Fortis Healthcare, Apollo Hospitals, Aurobindo Pharma, and Torrent Pharma as key stocks to watch.

Nifty Ends Near 25,200 On Buying In Metals, IT & Pharma; TCS Posts Q2 Earnings Beat

 Pharma stocks surged after tariff relief, while midcaps outperformed the benchmarks.

Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist

After eight days of losses, markets may see a cautious start as the RBI policy decision takes center stage. Stock-specific action is expected in pharma, auto, and PSU banking counters.


Will Trump’s 100% Tariffs Derail Indian Pharma Stocks? SEBI Analyst Flags Key Levels For Traders

The new U.S. duty has already triggered a slide in major Asian pharma names, raising concerns about how Indian peers will react in the coming weeks.

Breakout Signals: Analysts Turn Bullish On Sanghvi Movers, Aurobindo, Airtel, And More

Sanghvi Movers leads the analyst radar with a breakout-backed buy call, while HSCL, Aurobindo Pharma, Power Grid, and Airtel also show promising upside levels.


Aurobindo Pharma Ltd. engages in the manufacture of generic pharmaceutical and active pharmaceutical ingredients. It operates under the following geographical segments: India, USA, Europe, and Rest of the World. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	19.11	--	--	N/A
Q1 '26	17.26	17.86	3.46%	BEAT
Q4 '25	16.22	15.86	-2.24%	MISSED
Q3 '25	15.94	15.67	-1.71%	MISSED
Q2 '25	15.24	14.61	-4.15%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

AUROPHARMA.NSE Earnings

Upcoming Earnings: Q2 '26

Historical Earnings